Find Armodafinil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

Canada

0

Listed Dossiers

FDF DossiersDRUG PRODUCT COMPOSITIONS

191RELATED EXCIPIENT COMPANIES

284EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 112111-43-0, Nuvigil, (r)-modafinil, (-)-modafinil, (r)-(-)-modafinil, Cep-10953
Molecular Formula
C15H15NO2S
Molecular Weight
273.4  g/mol
InChI Key
YFGHCGITMMYXAQ-LJQANCHMSA-N
FDA UNII
V63XWA605I

Armodafinil
A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
1 2D Structure

Armodafinil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(R)-benzhydrylsulfinyl]acetamide
2.1.2 InChI
InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)/t19-/m1/s1
2.1.3 InChI Key
YFGHCGITMMYXAQ-LJQANCHMSA-N
2.1.4 Canonical SMILES
C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
2.1.5 Isomeric SMILES
C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N
2.2 Other Identifiers
2.2.1 UNII
V63XWA605I
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2 Benzhydrylsulfinylacetamide

2. 2-((diphenylmethyl)sulfinyl)acetamide

3. 2-((r)-(diphenylmethyl)sulfinyl)acetamide

4. 2-(benzhydrylsulfinyl)acetamide

5. 2-benzhydrylsulfinylacetamide

6. Alertec

7. Benzhydrylsulfinylacetamide

8. Crl 40476

9. Crl-40476

10. Modafinil

11. Modiodal

12. Nuvigil

13. Provigil

14. R Modafinil

15. R-modafinil

16. Sparlon

2.3.2 Depositor-Supplied Synonyms

1. 112111-43-0

2. Nuvigil

3. (r)-modafinil

4. (-)-modafinil

5. (r)-(-)-modafinil

6. Cep-10953

7. Crl 40982

8. Modafinil, (r)-

9. R-(-)-modafinil

10. 2-[(r)-(diphenylmethyl)sulfinyl]acetamide

11. (-)-(r)-modafinil

12. Cep 10953

13. Cep-10952

14. Crl-40982

15. V63xwa605i

16. Chembl1201192

17. Chebi:77590

18. Nsc-751850

19. Nsc-758711

20. (-)-2-((r)-(diphenylmethyl)sulfinyl)acetamide

21. Acetamide, 2-((diphenylmethyl)sulfinyl)-, (-)-

22. Armodafinil [inn]

23. (-)-2-[(r)-(diphenylmethyl)sulfinyl]acetamide

24. Armodafinil [usan:inn]

25. Armodafinilo

26. Armodafinilum

27. Unii-v63xwa605i

28. L-modafinil

29. (-) Modafinil

30. Nuvigil (tn)

31. Armodafinil (usan/inn)

32. Armodafinil [usan]

33. Armodafinil [vandf]

34. Armodafinil [mart.]

35. Schembl34489

36. Armodafinil [usp-rs]

37. Armodafinil [who-dd]

38. Zinc6156

39. Armodafinil, >=98% (hplc)

40. Armodafinil [orange Book]

41. Dtxsid90920667

42. 2-[(r)-benzhydrylsulfinyl]acetamide

43. Bdbm50336892

44. Akos030211019

45. At22562

46. Ccg-230228

47. Cs-0665

48. Db06413

49. Nsc 751850

50. Nsc 758711

51. 2-[(r)-diphenylmethanesulfinyl]acetamide

52. Hy-15201

53. (-)-2r-[(diphenylmethyl)sulfinyl]acetamide

54. S4645

55. D03215

56. Q418913

57. Acetamide, 2-((r)-(diphenylmethyl)sulfinyl)-

2.4 Create Date
2006-10-24
3 Chemical and Physical Properties
Molecular Weight 273.4 g/mol
Molecular Formula C15H15NO2S
XLogP31.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count5
Exact Mass273.08234989 g/mol
Monoisotopic Mass273.08234989 g/mol
Topological Polar Surface Area79.4 Ų
Heavy Atom Count19
Formal Charge0
Complexity302
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameArmodafinil
PubMed HealthArmodafinil (By mouth)
Drug ClassesCNS Stimulant
Drug LabelNUVIGIL (armodafinil) is a wakefulness-promoting agent for oral administration. Armodafinil is the R-enantiomer of modafinil which is a mixture of the R- and S-enantiomers. The chemical name for armodafinil is 2-[(R)-(diphenylmethyl)sulfinyl]acetam...
Active IngredientArmodafinil
Dosage FormTablet
Routeoral; Oral
Strength2500mg; 200mg; 250mg; 100mg; 50mg; 150mg
Market StatusTentative Approval; Prescription
CompanyWatson Labs; Mylan Pharms; Teva Pharms Usa; Lupin

2 of 4  
Drug NameNuvigil
PubMed HealthArmodafinil (By mouth)
Drug ClassesCNS Stimulant
Drug LabelNUVIGIL (armodafinil) is a wakefulness-promoting agent for oral administration. Armodafinil is the R-enantiomer of modafinil which is a mixture of the R- and S-enantiomers. The chemical name for armodafinil is 2-[(R)-(diphenylmethyl)sulfinyl]acetam...
Active IngredientArmodafinil
Dosage FormTablet
RouteOral
Strength200mg; 250mg; 150mg; 50mg
Market StatusPrescription
CompanyCephalon

3 of 4  
Drug NameArmodafinil
PubMed HealthArmodafinil (By mouth)
Drug ClassesCNS Stimulant
Drug LabelNUVIGIL (armodafinil) is a wakefulness-promoting agent for oral administration. Armodafinil is the R-enantiomer of modafinil which is a mixture of the R- and S-enantiomers. The chemical name for armodafinil is 2-[(R)-(diphenylmethyl)sulfinyl]acetam...
Active IngredientArmodafinil
Dosage FormTablet
Routeoral; Oral
Strength2500mg; 200mg; 250mg; 100mg; 50mg; 150mg
Market StatusTentative Approval; Prescription
CompanyWatson Labs; Mylan Pharms; Teva Pharms Usa; Lupin

4 of 4  
Drug NameNuvigil
PubMed HealthArmodafinil (By mouth)
Drug ClassesCNS Stimulant
Drug LabelNUVIGIL (armodafinil) is a wakefulness-promoting agent for oral administration. Armodafinil is the R-enantiomer of modafinil which is a mixture of the R- and S-enantiomers. The chemical name for armodafinil is 2-[(R)-(diphenylmethyl)sulfinyl]acetam...
Active IngredientArmodafinil
Dosage FormTablet
RouteOral
Strength200mg; 250mg; 150mg; 50mg
Market StatusPrescription
CompanyCephalon

4.2 Drug Indication

Investigated for use/treatment in sleep disorders, obstructive sleep apnea, schizophrenia and schizoaffective disorders, depression, and bipolar disorders.


FDA Label


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Central Nervous System Stimulants

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)


Cytochrome P-450 CYP3A Inducers

Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inducers.)


Wakefulness-Promoting Agents

A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES. (See all compounds classified as Wakefulness-Promoting Agents.)


5.2 ATC Code

N - Nervous system

N06 - Psychoanaleptics

N06B - Psychostimulants, agents used for adhd and nootropics

N06BA - Centrally acting sympathomimetics

N06BA13 - Armodafinil


5.3 Absorption, Distribution and Excretion

Absorption

Tmax is 2 hours when fasted and can be delayed approximately 2-4 hours by food, potentially affecting the onset of action.


Volume of Distribution

Apparent volume of distribution: 42L.


Clearance

The oral clearance of armodafinil is approximately 33 mL/min.


5.4 Metabolism/Metabolites

In vitro and in vivo data show that armodafinil undergoes hydrolytic deamidation, S-oxidation, and aromatic ring hydroxylation, with subsequent glucuronide conjugation of the hydroxylated products. Amide hydrolysis is the single most prominent metabolic pathway, with sulfone formation by cytochrome P450 (CYP) 3A4/5 being next in importance. The other oxidative products are formed too slowly in vitro to enable identification of the enzyme(s) responsible. Only two metabolites reach appreciable concentrations in plasma (i.e., R-modafinil acid and modafinil sulfone). Data specific to armodafinil disposition are not available.


5.5 Biological Half-Life

Terminal half-life is approximately 15 hours.


5.6 Mechanism of Action

Nuvigil (armodafinil) is a single-isomer of modafini. The exact mechanism of action is unknown. Armodafinil belongs to a class of drugs known as eugeroics, which are stimulants that provide long-lasting mental arousal. Pharmacologically, armodafinil does not bind to or inhibit several receptors and enzymes potentially relevant for sleep/wake regulation. Armodafinil is not a direct- or indirect-acting dopamine receptor agonist. However, in vitro, both armodafinil and modafinil bind to the dopamine transporter and inhibit dopamine reuptake. [Medilexicon]


API SUPPLIERS

read-more
read-more

01

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, ASMF arrow-down AUDIT
HRV Global Life Sciences

02

Unimark Remedies

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

03

Lupin Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Lupin Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

04

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

05

Orchid Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Orchid Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

06

CEPHALON INC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

CEPHALON INC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

08

Piramal Pharma Solutions

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Piramal Pharma Solutions

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT arrow-down
blank

09

Chromo Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Chromo Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Aurobindo Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Aurobindo Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT arrow-down
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

02

Actavis Group Ptc Ehf

Ireland

USDMF

arrow
AACR Annual meeting
Not Confirmed

02

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 22983

Submission : 2009-07-24

Status : Active

Type : II

blank

03

AACR Annual meeting
Not Confirmed

03

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-08-28

Pay. Date : 2013-07-24

DMF Number : 27302

Submission : 2013-07-29

Status : Active

Type : II

blank

04

Cephalon Inc

U.S.A

USDMF

arrow
AACR Annual meeting
Not Confirmed

04

Cephalon Inc

U.S.A
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19685

Submission : 2006-08-15

Status : Active

Type : II

blank

06

Orchid Pharma Ltd

India

USDMF

arrow
AACR Annual meeting
Not Confirmed

06

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 25031

Submission : 2011-06-23

Status : Active

Type : II

blank

07

Tapi Nl Bv

Israel

USDMF

arrow
AACR Annual meeting
Not Confirmed

07

Tapi Nl Bv

Israel
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 30350

Submission : 2016-04-20

Status : Active

Type : II

blank

08

AACR Annual meeting
Not Confirmed

08

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 22957

Submission : 2009-07-17

Status : Inactive

Type : II

blank

09

AACR Annual meeting
Not Confirmed

09

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2017-05-02

Pay. Date : 2017-04-20

DMF Number : 21200

Submission : 2007-12-19

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

02

Natco Pharma

India
AACR Annual meeting
Not Confirmed
arrow

Natco Pharma

India
arrow
AACR Annual meeting
Not Confirmed

Armodafinil Ph. Eur

Date of Issue : 2025-06-30

Valid Till : 2028-06-22

Written Confirmation Number : WC-014

Address of the Firm : Situated at Chemical Division, Mekaguda (Village), Nandigama (Mandal), Ranga Red...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

NDC Package Code : 65862-795

Start Marketing Date : 2023-11-03

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

NDC Package Code : 72761-001

Start Marketing Date : 2019-02-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

NDC Package Code : 48087-0066

Start Marketing Date : 2010-04-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

NDC Package Code : 65085-0058

Start Marketing Date : 2022-07-26

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

NDC Package Code : 11722-055

Start Marketing Date : 2014-07-25

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (100kg/100kg)

Marketing Category : BULK INGREDIENT

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

NDC Package Code : 65129-1185

Start Marketing Date : 2006-07-27

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Matrix Pharmacorp Private Limited

Country
AACR Annual meeting
Not Confirmed
arrow

Matrix Pharmacorp Private Limited

Country
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

NDC Package Code : 84206-0010

Start Marketing Date : 2024-08-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

WATSON LABS INC

Ireland
AACR Annual meeting
Not Confirmed
arrow

WATSON LABS INC

Ireland
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : ARMODAFINIL

Dosage Form : TABLET; ORAL

Dosage Strength : 150MG

Approval Date :

Application Number : 200156

RX/OTC/DISCN :

RLD :

TE Code :

blank

02

WATSON LABS INC

Ireland
AACR Annual meeting
Not Confirmed
arrow

WATSON LABS INC

Ireland
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : ARMODAFINIL

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Approval Date : 2012-08-29

Application Number : 200156

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : ARMODAFINIL

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Approval Date : 2018-03-06

Application Number : 206069

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : ARMODAFINIL

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Approval Date : 2018-03-06

Application Number : 206069

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

COREPHARMA

U.S.A
AACR Annual meeting
Not Confirmed
arrow

COREPHARMA

U.S.A
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : ARMODAFINIL

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Approval Date : 2019-03-25

Application Number : 201514

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

COREPHARMA

U.S.A
AACR Annual meeting
Not Confirmed
arrow

COREPHARMA

U.S.A
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : ARMODAFINIL

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Approval Date : 2019-03-25

Application Number : 201514

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

NUVO PHARMS

Canada
AACR Annual meeting
Not Confirmed
arrow

NUVO PHARMS

Canada
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : NUVIGIL

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Approval Date : 2007-06-15

Application Number : 21875

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

08

NUVO PHARMS

Canada
AACR Annual meeting
Not Confirmed
arrow

NUVO PHARMS

Canada
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : NUVIGIL

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2009-03-26

Application Number : 21875

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

09

NUVO PHARMS

Canada
AACR Annual meeting
Not Confirmed
arrow

NUVO PHARMS

Canada
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : NUVIGIL

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Approval Date : 2007-06-15

Application Number : 21875

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ARMODAFINIL

Brand Name : ARMODAFINIL

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Approval Date :

Application Number : 200152

RX/OTC/DISCN :

RLD :

TE Code :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Modafinil

Brand Name : Modafinil \"Orion\"

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 26-11-2015

Application Number : 28105501014

Regulatory Info : Prescription

Registration Country : Denmark

Fermion Orion Company Banner

02

Modafinil

Brand Name : Modafinil \"Orion\"

Dosage Form : Tablet

Dosage Strength : 200mg

Packaging :

Approval Date : 26-11-2015

Application Number : 28105501114

Regulatory Info : Prescription

Registration Country : Denmark

Fermion Orion Company Banner

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Aspendos 100 mg

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 01-11-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Aspendos 100 mg

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 01-11-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Aspendos 100 mg

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 01-11-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Aspendos 100 mg

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 01-11-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Modafinil \"Orifarm\"

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 09-06-2009

Application Number : 28104316708

Regulatory Info : Prescription

Registration Country : Denmark

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Modiodal

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 24-11-1997

Application Number : 28101700794

Regulatory Info : Prescription

Registration Country : Denmark

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Myldamo

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 27-06-2018

Application Number : 28105951617

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

Nordic Prime Aps

Country
AACR Annual meeting
Not Confirmed
arrow

Nordic Prime Aps

Country
arrow
AACR Annual meeting
Not Confirmed

Modafinil

Brand Name : Modapram

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 21-01-2022

Application Number : 28106523120

Regulatory Info : Prescription

Registration Country : Denmark

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 100MG **Federal Regist...DOSAGE - TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21875

read-more

DOSAGE - TABLET;ORAL - 150MG

USFDA APPLICATION NUMBER - 21875

read-more

DOSAGE - TABLET;ORAL - 200MG

USFDA APPLICATION NUMBER - 21875

read-more

DOSAGE - TABLET;ORAL - 250MG

USFDA APPLICATION NUMBER - 21875

read-more

DOSAGE - TABLET;ORAL - 50MG

USFDA APPLICATION NUMBER - 21875

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Solubilizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Parenteral

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 112111-43-0 / Armodafinil API manufacturers, exporters & distributors?

Armodafinil manufacturers, exporters & distributors 1

17

PharmaCompass offers a list of Armodafinil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Armodafinil manufacturer or Armodafinil supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Armodafinil manufacturer or Armodafinil supplier.

API | Excipient name

Armodafinil

Synonyms

112111-43-0, Nuvigil, (r)-modafinil, (-)-modafinil, (r)-(-)-modafinil, Cep-10953

Cas Number

112111-43-0

Unique Ingredient Identifier (UNII)

V63XWA605I

About Armodafinil

A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.

Armodafinil Manufacturers

A Armodafinil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Armodafinil, including repackagers and relabelers. The FDA regulates Armodafinil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Armodafinil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Armodafinil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Armodafinil Suppliers

A Armodafinil supplier is an individual or a company that provides Armodafinil active pharmaceutical ingredient (API) or Armodafinil finished formulations upon request. The Armodafinil suppliers may include Armodafinil API manufacturers, exporters, distributors and traders.

click here to find a list of Armodafinil suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Armodafinil USDMF

A Armodafinil DMF (Drug Master File) is a document detailing the whole manufacturing process of Armodafinil active pharmaceutical ingredient (API) in detail. Different forms of Armodafinil DMFs exist exist since differing nations have different regulations, such as Armodafinil USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Armodafinil DMF submitted to regulatory agencies in the US is known as a USDMF. Armodafinil USDMF includes data on Armodafinil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Armodafinil USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Armodafinil suppliers with USDMF on PharmaCompass.

Armodafinil KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Armodafinil Drug Master File in Korea (Armodafinil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Armodafinil. The MFDS reviews the Armodafinil KDMF as part of the drug registration process and uses the information provided in the Armodafinil KDMF to evaluate the safety and efficacy of the drug.

After submitting a Armodafinil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Armodafinil API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Armodafinil suppliers with KDMF on PharmaCompass.

Armodafinil WC

A Armodafinil written confirmation (Armodafinil WC) is an official document issued by a regulatory agency to a Armodafinil manufacturer, verifying that the manufacturing facility of a Armodafinil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Armodafinil APIs or Armodafinil finished pharmaceutical products to another nation, regulatory agencies frequently require a Armodafinil WC (written confirmation) as part of the regulatory process.

click here to find a list of Armodafinil suppliers with Written Confirmation (WC) on PharmaCompass.

Armodafinil NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Armodafinil as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Armodafinil API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Armodafinil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Armodafinil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Armodafinil NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Armodafinil suppliers with NDC on PharmaCompass.

Armodafinil GMP

Armodafinil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Armodafinil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Armodafinil GMP manufacturer or Armodafinil GMP API supplier for your needs.

Armodafinil CoA

A Armodafinil CoA (Certificate of Analysis) is a formal document that attests to Armodafinil's compliance with Armodafinil specifications and serves as a tool for batch-level quality control.

Armodafinil CoA mostly includes findings from lab analyses of a specific batch. For each Armodafinil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Armodafinil may be tested according to a variety of international standards, such as European Pharmacopoeia (Armodafinil EP), Armodafinil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Armodafinil USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty